Terms ending in 2030
Every in-force patent on Kymab Limited's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,434,782 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 9,447,177 | Transgenic Mouse Homozygous for Chimeric IgH Locus In force · Medium confidence | Kymab Limited | In force | Medium confidence | |
| US 9,504,236 | Animal Models and Therapeutic Molecules In force · High confidence | Kymab Limited | In force | High confidence | |
| US 9,505,827 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 10,064,398 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 10,165,763 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 11,564,380 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 11,606,941 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence | |
| US 11,812,731 | Animal Models and Therapeutic Molecules In force · Low confidence | Kymab Limited | In force | Low confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.